HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+16.91%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$276M
AUM Growth
+$59.5M
(+28%)
Cap. Flow
+$45.5M
Cap. Flow
% of AUM
16.5%
Top 10 Holdings %
Top 10 Hldgs %
29.49%
Holding
157
New
25
Increased
65
Reduced
12
Closed
31
Top Buys
| 1 |
Spyre Therapeutics
SYRE
|
$12.4M |
| 2 |
HES
Hess
HES
|
$4.17M |
| 3 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
$4.07M |
| 4 |
SP
SP Plus Corporation
SP
|
$4.04M |
| 5 |
UiPath
PATH
|
$3.07M |
Top Sells
Sector Composition
| 1 | Healthcare | 45.71% |
| 2 | Technology | 11.75% |
| 3 | Consumer Discretionary | 6.51% |
| 4 | Industrials | 5.31% |
| 5 | Consumer Staples | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Sera Prognostics
SERA
$131M
| $122K | 0.04% |
+20,480
| New | +$122K |
|
127
Acadia Pharmaceuticals
ACAD
$4.31B
| – | – |
-18,172
| Closed | -$379K |
|
128
Akero Therapeutics
AKRO
$3.64B
| – | – |
-11,408
| Closed | -$577K |
|
129
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-17,482
| Closed | -$481K |
|
130
Camden Property Trust
CPT
$11.7B
| – | – |
-5,800
| Closed | -$549K |
|
131
Caesars Entertainment
CZR
$5.15B
| – | – |
-14,200
| Closed | -$658K |
|
132
89bio
ETNB
$1.36B
| – | – |
-33,792
| Closed | -$522K |
|
133
HCA Healthcare
HCA
$95.7B
| – | – |
-2,911
| Closed | -$716K |
|
134
Hilton Worldwide
HLT
$65B
| – | – |
-4,800
| Closed | -$721K |
|
135
Incyte
INCY
$17B
| – | – |
-8,158
| Closed | -$471K |
|
136
Krystal Biotech
KRYS
$4.31B
| – | – |
-4,392
| Closed | -$509K |
|
137
Netflix
NFLX
$521B
| – | – |
-1,444
| Closed | -$545K |
|
138
Natera
NTRA
$23B
| – | – |
-10,066
| Closed | -$445K |
|
139
Palo Alto Networks
PANW
$127B
| – | – |
-5,410
| Closed | -$634K |
|
140
Prothena Corp
PRTA
$449M
| – | – |
-9,195
| Closed | -$444K |
|
141
PTC Therapeutics
PTCT
$4.4B
| – | – |
-13,237
| Closed | -$297K |
|
142
Ultragenyx Pharmaceutical
RARE
$3.02B
| – | – |
-14,591
| Closed | -$520K |
|
143
RXO
RXO
$2.64B
| – | – |
-40,683
| Closed | -$803K |
|
144
Syndax Pharmaceuticals
SNDX
$1.4B
| – | – |
-29,490
| Closed | -$428K |
|
145
Sarepta Therapeutics
SRPT
$1.95B
| – | – |
-4,781
| Closed | -$580K |
|
146
TKO Group
TKO
$15.3B
| – | – |
-5,907
| Closed | -$497K |
|
147
Uber
UBER
$192B
| – | – |
-12,500
| Closed | -$575K |
|
148
UnitedHealth
UNH
$278B
| – | – |
-1,200
| Closed | -$605K |
|
149
Vera Therapeutics
VERA
$1.45B
| – | – |
-30,902
| Closed | -$424K |
|
150
United Parks & Resorts
PRKS
$2.98B
| – | – |
-14,488
| Closed | -$670K |
|